Jeremy Grantham Charles River Laboratories International, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$123.4 - $148.55 $592,320 - $713,040	-4,800 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$104.82 - $146.73 $31,445 - $44,019	300 Added 6.67%	4,800 $697,000
Q4 2018 Feb 13, 2019	BUY	$105.09 - $137.23 $178,653 - $233,290	1,700 Added 60.71%	4,500 $509,000
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $313,908 - $376,712	2,800 New	2,800 $377,000
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $343,665 - $403,200	-3,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $30,129 - $35,427	300 Added 9.38%	3,500 $383,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,200	3,200 $324,000

694

52M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.49B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.